|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Immuneering (NASDAQ: IMRX) through any online brokerage.
The latest price target for Immuneering (NASDAQ: IMRX) was reported by Cowen & Co. on August 24, 2021. The analyst firm set a price target for 0.00 expecting IMRX to fall to within 12 months (a possible -100.00% downside). 4 analyst firms have reported ratings in the last year.
The stock price for Immuneering (NASDAQ: IMRX) is $27.49 last updated Fri Sep 24 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Immuneering.
There is no upcoming split for Immuneering.
Immuneering is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.